Complement receptor drug targetting
See also Complement Receptors under Immunology CR2 Fusion Constructs CR2-FH fusion proteins: Gilkeson (US 7759304; US2008/0221011A1) and WO2007/149567A2) discloses a CR2-FH fusion construct which can be used to treat diseases in…